Patent Filing
Stimulation suspension in response to patient discomfort or state
Livanova Usa, Inc.8/19/2025·08/19/25🌐 USA
Summary
This patent describes implantable neurostimulation systems that can automatically suspend stimulation when patient discomfort events are detected. The system monitors for indicators such as coughing, throat irritation, or voice changes and temporarily pauses therapy to improve patient comfort during vagus nerve stimulation.
Why it matters
Automatic stimulation suspension addresses common side effects that limit patient tolerance of vagus nerve stimulation therapy. This technology improves the patient experience with LivaNova's VNS Therapy System, potentially increasing therapy adherence and enabling higher therapeutic doses that might otherwise be limited by side effects.
#Closed-Loop#Neurostimulation#Epilepsy#Bioelectronic Medicine#USA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in